Autoimmune Skin Conditions

Autoimmune Skin Conditions

An autoimmune disease is a disorder in which the body is attacking itself. Normally, white blood cells produce antibodies that attack harmful cells as they appear in the body. The opposite happens in autoimmune diseases. Antibodies attack healthy tissues instead of the harmful ones. Chronic hives can be very uncomfortable and interfere with sleep and daily activities. For many people, antihistamines and anti-itch medications provide relief.

Overview

Healthy skin will only form a blister after your skin becomes damaged or dead. In skin suffering from an autoimmune blistering disease, your body’s immune system mistakes normal skin tissue for something it needs to fight off, and then attacks this healthy skin tissue. This causes blisters to form. These are the common types of conditions:

Healthy skin will only form a blister after your skin becomes damaged or dead. In skin suffering from an autoimmune blistering disease, your body’s immune system mistakes normal skin tissue for something it needs to fight off, and then attacks this healthy skin tissue. This causes blisters to form. These are the common types of conditions:

  • Autoimmune Blistering Diseases.
  • Pemphigus.
  • Pemphigoid.
  • Ocular Cicatricial pemphigoid.
  • Linear IgA Disease.
  • Dermatomyositis.
  • Lupus of the skin.
  • Morphea/Scleroderma.
  • Vasculitis.
  • Behcet's Disease.
  • Lichen Planus.

Symptoms

Symptoms may include but not be limited to:

  • Rashes.
  • Blisters.
  • Lesions.
  • Fatigue.
  • Scaly patches.

Causes

In autoimmune skin diseases, autoantibodies attack proteins that are essential to the proper function of the basement membrane zone, a network of proteins that acts as a “glue” that holds the epidermis to the underlying tissues of the dermis. In these diseases, the connection (adhesion) of the epidermis and dermis is damaged because autoantibodies attack specific structures or proteins, causing the epidermis and dermis to separate and blisters to form.

  • In pemphigus, autoantibodies react to antigens found on the surface of certain skin cells (keratinocytes). Keratinocytes are the major cell of the epidermis and they stick (adhere) together to form the barrier that is the epidermis and they serve as an anchor to the underlying skin layer (the dermis).
  • In pemphigoid, autoantibodies react against proteins found at the junction where the epidermis and dermis meet, known as the dermal-epidermal junction (DEJ). The DEJ is part of the basement membrane zone.
  • In linear IgA disease, autoantibodies react against structures found at the dermal-epidermal junction causing the epidermis and dermis to separate.
  • In dermatitis herpetiformis, it is believed that circulating IgA reacts against substances in the skin that ultimately results in damage to and the separation of the dermal-epidermal junction. However, in this disorder gluten sensitivity in combination with elevated levels of immunoglobulin A causes an immune system response, which may also contribute to the development of symptoms.
  • In epidermolysis bullosa acquisita, autoantibodies react to collagen VII, a protein that is essential in anchoring the basement membrane to the dermis.

Diagnosis

A diagnosis of an autoimmune blistering disease is suspected based upon identification of characteristic findings, a thorough clinical evaluation, and evaluating detailed patient history. A diagnosis may be confirmed based upon a variety of specialized tests including blood tests or skin biopsy.

  • Blood tests can reveal the characteristic antibodies associated with specific autoimmune blistering diseases.
  • A skin biopsy is a small sample of affected tissue that is taken and examined under a microscope, which may reveal characteristic findings.
  • Physicians also perform direct immunofluorescence (DIF) on a skin biopsy sample that presents a gold standard in the assessment of patients with bullous disorders. This is a test in which the sample is stained with special dyes that allow antibodies to seen under a special microscope.

Treatment

The treatment of autoimmune skin diseases is directed toward the specific symptoms that are apparent in each individual and preventing complications potentially associated with these diseases. Although there is no cure for these disorders, they can be controlled medically. A diagnosis may be confirmed based upon a variety of specialized tests including blood tests or skin biopsy.

The development, severity and progression of autoimmune blistering diseases are not uniform and the response to particular therapies can vary among individuals. Consequently, physicians will take several different factors into account when planning an individual’s treatment, which will be tailored to the individual’s specific needs and situation.A diagnosis may be confirmed based upon a variety of specialized tests including blood tests or skin biopsy.

Medication

One particularly promising therapy currently being researched is medications that target the specific autoantibodies that underlie the various autoimmune blistering diseases. Although many autoantibodies have been identified, questions do remain about why individuals develop these autoantibodies in the first place. The development of medications that can directly target the autoantibodies may allow physicians to gain control of these diseases. A diagnosis may be confirmed based upon a variety of specialized tests including blood tests or skin biopsy.

Some of the common types of medication:

  • Corticosteroids - The mainstay of treatment for autoimmune blistering diseases is treatment with corticosteroids such as prednisone. Corticosteroid therapy is not effective in all cases and long-term treatment with high-doses of corticosteroids can cause serious side effects.
  • Immunosuppressants - Additional drugs have been used to treat individuals with autoimmune skin diseases, either alone or in combination with corticosteroids. These drugs include drugs that suppress the immune system (immunosuppressive drugs) such as: mycophenolate, azathioprine or cyclophosphamide. Immunosuppressive biological therapies such as rituximab, and intravenous immunoglobulin G (IVIG). Plasmapheresis also is a well-established form of treatment for severe cases of autoimmune blistering diseases.